Infinitus Systems Stock
| Valuation | $583.87M1 |
| Valuation Date | Oct 23, 2024 |
| Implied Valuation | $583.87M |
| Last Price | $6.05 |
| 52-Week High | $6.05 |
| 52-Week Low | $6.05 |
| YTD Return | +0.00% |
| 1-Year Return | +0.00% |
| 3-Year Return | n/a |
| Total Funding | $102.9M2 |
| Latest Round Amount | $51.5M2 |
| Latest Round | Series C |
| Funding Rounds | 4 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Infinitus Systems
Infinitus Systems builds AI voice agents that automate administrative and clinical phone calls in the US healthcare industry, such as insurance benefit verification, prior authorization follow-up, and patient support and outreach. Its platform combines conversational AI agents with safety guardrails, a healthcare knowledge graph, and human-in-the-loop oversight, and includes Studio (a no-code agent builder), Lens (a conversation evaluation engine), and Workflows (multi-agent orchestration). The company sells to pharmaceutical manufacturers, payors, providers, and pharmacies, and says it supports 44% of Fortune 50 healthcare companies.
Invest in Infinitus Systems
Infinitus Systems is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
Related Companies
News
Infinitus Launches AI-First, Human-Backed Hub Solution to Replace Specialty Pharma's Legacy Call-Center Infrastructure
Infinitus announced an AI-first hub model in July 2026 that combines AI agents and human experts across the patient journey to replace legacy specialty-pharma call-center infrastructure.
Infinitus Launches AI-First Hub Solution for Specialty Pharma
Infinitus unveiled an end-to-end AI-first hub model to replace legacy specialty-pharma call-center infrastructure, routing complex cases to certified human experts automatically.
Infinitus Launches Clinical Escalations for Healthcare AI Agents
Infinitus introduced Clinical Escalations, a real-time clinical risk detection system that helps healthcare AI agents triage patient conversations and route emergencies appropriately.
Meet Workflows: Multi-agent orchestration for end-to-end healthcare journeys
Infinitus launched Workflows, an orchestration layer that coordinates AI agents, human teams, APIs, and third-party systems into continuous end-to-end patient journeys.
Infinitus Introduces The First Solution to Evaluate Every Healthcare Interaction Led by AI or Humans
Infinitus announced Lens, a conversation insights engine that scores both AI agent calls and human-led calls on the same criteria to give healthcare organizations visibility into every interaction.
Infinitus Launches Studio, the First Healthcare-Specific No-Code AI Agent Builder
Infinitus launched Studio, a no-code AI agent builder for healthcare that lets payors and pharmaceutical companies design, test, and deploy AI agents through a natural-language interface.
Infinitus Partners with IBM Consulting on Agentic AI for Specialty Pharmacy
Infinitus and IBM Consulting are collaborating to bring agentic AI into specialty pharmacy workflows, aiming to reduce prior-auth cycle times and speed patients to therapy.
Introducing Infinitus' next generation of clinical AI agents
Infinitus introduced a new generation of patient-facing clinical AI agents with clinical awareness, adverse-event escalation, and Spanish-language support for patient education and care management.
Infinitus launches DTP solution to help pharma reimagine the patient relationship
Infinitus announced an agentic AI suite for pharmaceutical direct-to-patient programs, covering 24/7 patient support, proactive outreach, real-time copay estimates, and adherence engagement.
Infinitus deepens partnership with Salesforce to accelerate AI agent adoption in healthcare and life sciences
Infinitus expanded its Salesforce partnership so joint customers can launch its voice AI agents from Health Cloud and Life Sciences Cloud via Agentforce and MuleSoft connectors to verify benefits cove...
Infinitus Launches Hallucination-Free Voice AI Agent for Healthcare
Infinitus launched voice AI agents built on a hallucination-free architecture combining a discrete action space, a dynamic knowledge graph, an AI review layer, and HIPAA-compliant infrastructure.
Infinitus Systems Raises $51.5M Series C Led by Andreessen Horowitz
Infinitus raised $51.5 million in Series C funding to automate healthcare phone calls, bringing total funding to $102.9 million at a reported $584 million valuation.
Infinitus Systems raises $51.5 million Series C funding on the strength of AI guardrails
Infinitus raised a $51.5 million Series C led by Andreessen Horowitz with Memorial Hermann Health System, Kleiner Perkins, Coatue, and GV, bringing total funding to $102.9 million.
These Former Googlers Raised $30 Million To Automate Phone Calls With Health Insurers
Infinitus raised a $30 million Series B led by GV with participation from Kleiner Perkins and Coatue, reportedly valuing the company at $275 million.
Infinitus emerges from stealth with $21.4M for 'voice RPA' aimed at healthcare companies
Infinitus came out of stealth with $21.4 million in seed and Series A funding co-led by Kleiner Perkins and Coatue to automate phone calls between healthcare organizations.